Erlotinib (Tarceva®): a promising drug targeting epidermal growth factor receptor tyrosine kinase
Overexpression of the epidermal growth factor receptor (EGFR) is correlated with a poor prognosis in several human malignancies. In addition, cancers overexpressing EGFR respond...